“I am excited to introduce the first wave of TechLuxe in a form of a resin handbag with an LCD video screen. The idea is to radically bring technology to fashion, but with creative beauty within a functional beautifully designed bag.”
Undoubtedly one of the most exciting areas within the 3D printing space is that of bioprinting. Using layer-by-layer fabrication methods, a number of companies are in the process of pushing forward a new paradigm shift within the medical implant, transplantation, and surgical spaces. While the media has mainly focused on Organovo, the company behind the world’s first 3D printable liver tissue, there are actually several other companies involved in this incredible space. Here are 3DPrint.com we thought it would be helpful to underline just a handful of those companies that may be about to change medicine as we know it.
Organovo The company, headquartered in San Diego, California, has been at the forefront of 3D bioprinting research for some time now. Not only are they currently bringing revenues in by providing pharmaceutical companies with their 
exVive3D™ Liver Tissue for drug toxicity testing, but they have partnered with major companies in the health space including L’Oréal and Merck, and are planning on introducing their exVive3D™ Kidney Tissue product by next year. With an ultimate goal of 3D printing patches made of human tissue for failing organs, and eventually entire organs for transplantation, Organovo certainly has their work cut out for them.
Last week, the FDA approved the first 3D-printed prescription drug, essentially validating the technology as a new heavyweight player in big pharma. “This may be the first truly mass manufactured product made by 3D printing,” said Dr. Michael Cima, a professor at MIT who helped invent the pill-printing technology back in 1997, in an email to Singularity Hub. “It’s revolutionary.”
The printed pill, SPRITAM levetiracetam, is a drug that fights many kinds of epileptic seizures. The brainchild of a little-known Ohio-based company Aprecia, SPRITAM is essentially an old drug ingredient packaged into a brand new, more effective delivery system. Unlike current formulations of the same drug, SPRITAM immediately dissolves upon contact with water and bursts into effect — a property obviously beneficial when trying to curtail sudden-onset seizure episodes.
Checkout the latest Longevity Reporter Newsletter (15th August, 2015), covering this week’s top news in health, aging, longevity
This week: ‘Danielle’ — An Eye Opening Simulation Of The Aging Process; How Does Chronic Inflammation Lead To Cancer?; Low Inflammation and Telomere Maintenance Predict Healthy Longevity; 3-D Printing: Could Downloadable Medicine Be The Future?; And more.
I’m a firm believer that technology can take us to unimaginable places, from both a physical and a mental standpoint. Technological progress is oftentimes cha.
At the end of last year, Made In Space made what was a huge achievement for 3D printing in space by sending their Zero G 3D printer, capable of 3D printing without gravity, to the International Space Station. There, it has 3D printed numerous components, including a now famous wrench and twenty-three other prints that have since returned to Earth for lab analysis. The ability to 3D print without gravity restraints will allow those aboard the ISS to 3D print tools and parts using raw material, preventing the need for direct shipments of such objects from Earth. This ability is an exciting one, but the true goal of NASA and Made In Space has been to 3D print in vacuum of space itself. Today, Made In Space has announced that such a feat has now been proven possible through a series of tests performed here on Earth.
As 3-D printing gains steam and moves beyond plastics, it could be applied to many other industries, revolutionising medicine on the way.
An Ohio based pharmaceutical company Aprecia has now developed a 3-D printing technology which creates a more porous pill structure — allowing higher dose pills to dissolve quicker and making them easier to swallow for some patients. The same technology also allows precise doses to be layered in the same structure. A UCL team have also developed a technique for printing different shapes, which affects drug release.
“For the last 50 years, we have manufactured tablets in factories and shipped them to hospitals, for the first time, this process means we can produce tablets much closer to the patient.”
Researchers are working on a 3D printing pen that will allow surgeons draw regenerative cells onto injured body parts — the Biopen.
